Javascript must be enabled to continue!
Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId
View through CrossRef
AbstractWe report the molecular genetic abnormalities of a patient with GSD IIId presenting with progressive myopathy and cardiopathy leading to a fatal outcome. We identified two independent deletions including a 4 bp deletion (1117–1120) and a 98 bp deletion (1135–1232) in cDNA. Sequencing of the genomic DNA of the corresponding region revealed a 4 bp deletion in exon 10; however, the other 98 bp deletion corresponding to exon 11, which was deleted in cDNA, was present in genomic DNA. We therefore concluded that skipping of exon 11 occurred in the cDNA of the patient. Intron/exon boundary analysis of the skipped exon 11 revealed no mutation in the consensus splice‐site sequence. If normal splicing had occurred, a stop codon would have appeared within exon 11 due to frameshift mutation. The mechanism of exon skipping observed in our patient is as yet unknown, and it is still not clear whether intraexonal mutation of the preceding exon can influence splice‐site selection. It is possible that a unique exon skipping occurred, preventing the appearance of a stop codon in our patient
Title: Novel exon 11 skipping mutation in a patient with glycogen storage disease type IIId
Description:
AbstractWe report the molecular genetic abnormalities of a patient with GSD IIId presenting with progressive myopathy and cardiopathy leading to a fatal outcome.
We identified two independent deletions including a 4 bp deletion (1117–1120) and a 98 bp deletion (1135–1232) in cDNA.
Sequencing of the genomic DNA of the corresponding region revealed a 4 bp deletion in exon 10; however, the other 98 bp deletion corresponding to exon 11, which was deleted in cDNA, was present in genomic DNA.
We therefore concluded that skipping of exon 11 occurred in the cDNA of the patient.
Intron/exon boundary analysis of the skipped exon 11 revealed no mutation in the consensus splice‐site sequence.
If normal splicing had occurred, a stop codon would have appeared within exon 11 due to frameshift mutation.
The mechanism of exon skipping observed in our patient is as yet unknown, and it is still not clear whether intraexonal mutation of the preceding exon can influence splice‐site selection.
It is possible that a unique exon skipping occurred, preventing the appearance of a stop codon in our patient.
Related Results
Abstract 2819: Mass spectrometry imaging reveals heterogeneous glycogen metabolism in non small cell lung cancer
Abstract 2819: Mass spectrometry imaging reveals heterogeneous glycogen metabolism in non small cell lung cancer
Abstract
Lung cancer is the leading cause of cancer related death worldwide, with a high mortality rate even when diagnosed at an early stage. Identifying the unique...
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
Antisense oligonucleotides as a potential therapeutic strategy in hypertrophic cardiomyopathy caused by MYBPC3 variants
Abstract
Funding Acknowledgements
Type of funding sources: Foundation. Main funding source(s): Sociedad Española de Cardiología
...
Glycogen metabolism in cultured chick hepatocytes: A morphological study
Glycogen metabolism in cultured chick hepatocytes: A morphological study
AbstractUltrastructural and autoradiographic observations of cultured chick hepatocytes under the following conditins are described: Induction of glycogen synthesis with glucose al...
Autonomy on Trial
Autonomy on Trial
Photo by CHUTTERSNAP on Unsplash
Abstract
This paper critically examines how US bioethics and health law conceptualize patient autonomy, contrasting the rights-based, individualist...
Exon Skipping as a Therapeutic for Neurofibromatosis Type I
Exon Skipping as a Therapeutic for Neurofibromatosis Type I
Abstract
We investigated the feasibility of utilizing an exon skipping approach as a genotype-dependent therapeutic for neurofibromatosis type 1 (NF1) by determining which ...
Physiological Responses to Hypoxia in the Absence of Brain Glycogen
Physiological Responses to Hypoxia in the Absence of Brain Glycogen
Background and Hypothesis: Glycogen is a highly branched polymer of glucose and is an important form of energy storage in mammals. The brain is able to form glycogen in astrocytes ...
SERGE, the subcellular site of initial hepatic glycogen deposition in the rat: a radioautographic and cytochemical study.
SERGE, the subcellular site of initial hepatic glycogen deposition in the rat: a radioautographic and cytochemical study.
Hormonal control of hepatic glycogen and blood glucose levels is one of the major homeostatic mechanisms in mammals: glycogen is synthesized when portal glucose concentration is su...
Abstract 3046: In situ analysis of microenvironmental glycogen in Ewing's sarcoma patient samples by mass spectrometry imaging
Abstract 3046: In situ analysis of microenvironmental glycogen in Ewing's sarcoma patient samples by mass spectrometry imaging
Abstract
Ewing's sarcoma (ES) is a rare pediatric cancer of the bone and soft tissues affecting adolescents and young adults, with peak incidence from ages 10 to 15 ...

